- Home
- JELD vs HUMA Comparison
JELD vs HUMA Comparison
Compare JELD & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JELD
- HUMA
- Stock Information
- Founded
- JELD 1960
- HUMA 2004
- Country
- JELD United States
- HUMA United States
- Employees
- JELD N/A
- HUMA N/A
- Industry
- JELD Forest Products
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- JELD Basic Materials
- HUMA Health Care
- Exchange
- JELD Nasdaq
- HUMA Nasdaq
- Market Cap
- JELD 392.0M
- HUMA 324.0M
- IPO Year
- JELD 2017
- HUMA N/A
- Fundamental
- Price
- JELD $2.92
- HUMA $1.46
- Analyst Decision
- JELD Hold
- HUMA Strong Buy
- Analyst Count
- JELD 8
- HUMA 7
- Target Price
- JELD $6.03
- HUMA $10.00
- AVG Volume (30 Days)
- JELD 1.3M
- HUMA 5.5M
- Earning Date
- JELD 11-03-2025
- HUMA 11-07-2025
- Dividend Yield
- JELD N/A
- HUMA N/A
- EPS Growth
- JELD N/A
- HUMA N/A
- EPS
- JELD N/A
- HUMA N/A
- Revenue
- JELD $3,304,892,000.00
- HUMA $818,000.00
- Revenue This Year
- JELD N/A
- HUMA N/A
- Revenue Next Year
- JELD $2.44
- HUMA $1,468.13
- P/E Ratio
- JELD N/A
- HUMA N/A
- Revenue Growth
- JELD N/A
- HUMA N/A
- 52 Week Low
- JELD $2.31
- HUMA $1.15
- 52 Week High
- JELD $14.65
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- JELD 18.58
- HUMA 39.33
- Support Level
- JELD $4.61
- HUMA $1.65
- Resistance Level
- JELD $4.90
- HUMA $1.68
- Average True Range (ATR)
- JELD 0.27
- HUMA 0.10
- MACD
- JELD -0.10
- HUMA -0.02
- Stochastic Oscillator
- JELD 23.34
- HUMA 0.00
About JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential single and multi-family homes and non-residential buildings. The firm's operating segments are North America, Europe, and Australasia. It generates a majority of its revenue from North America.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.